Blood test may unlock targeted cancer drug for more patients
Diagnosis
Ongoing
This study looks at whether a blood test can detect certain genetic changes (FGFR mutations) in patients with advanced bladder cancer better than the standard tissue biopsy. Currently, only patients with these mutations found in tumor tissue can get the drug erdafitinib. The bloo…
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC